Repositorio
Institucional

Mente, Andrew

Bhavadharini, Balaji

Dehghan, Mahshid

Rangarajan, Sumathy

Sheridan, Patrick

Mohan, Viswanathan

Iqbal, Romaina

Gupta, Rajeev

Lear, Scott

Wentzel-Viljoen, Edelweiss

Avezum, Alvaro

Lopez-Jaramillo, Patricio

Mony, Prem

Varma, Ravi Prasad

Kumar, Rajesh

Chifamba, Jephat

Alhabib, Khalid F.

Mohammadifard, Noushin

Oguz, Aytekin

Lanas, Fernando

Rozanska, Dorota

Bostrom, Kristina Bengtsson

Yusoff, Khalid

Tsolkile, Lungiswa P.

Dans, Antonio

Yusufali, Afzalhussein

Orlandini, Andres

Poirier, Paul

Khatib, Rasha

Hu, Bo

Wei, Li

Yin, Lu

Deeraili, Ai

Yeates, Karen

Yusuf, Rita

Ismail, Noorhassim

Mozaffarian, Dariush

Teo, Koon

Anand, Sonia S.

Yusuf, Salim

Association of dairy consumption with metabolic syndrome, hypertension and diabetes in 147 812 individuals from 21 countries

BMJ PUBLISHING GROUP

BMJ OPEN DIABETES RESEARCH & CARE

en

artículo original

acceso abierto

The study was mainly funded by the Population Health Research Institute (PHRI). SY is supported by the Mary W Burke endowed chair of the Heart and Stroke Foundation of Ontario. The PURE study is an investigator--initiated study that is funded by the Population Health Research Institute, Hamilton Health Sciences Research Institute (HHSRI), the Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario, Support from Canadian Institutes of Health Research's Strategy for Patient Oriented Research, through the Ontario SPOR Support Unit, as well as the Ontario Ministry of Health and Long--Term Care and through unrestricted grants from several pharmaceutical companies (with major contributions from AstraZeneca (Canada), Sanofi--Aventis (France and Canada), Boehringer Ingelheim (Germany and Canada), Servier, and GlaxoSmithKline), and additional contributions from Novartis and King Pharma and from various national or local organizations in participating countries.These include: Argentina: Fundacion ECLA (Estudios Clinicos Latino America), Bangladesh: Independent University, Bangladesh and Mitra and Associates, Brazil: Unilever Health Institute, Brazil, Canada: this study was supported by an unrestricted grant from Dairy Farmers of Canada and the National Dairy Council (US), Public Health Agency of Canada and Champlain Cardiovascular Disease Prevention Network, Chile: Universidad de la Frontera, China: National Center for Cardiovascular Diseases and ThinkTank Research Center for Health Development, Colombia: Colciencias (grant 6566-04-18062 and grant 6517-777-58228), India: Indian Council of Medical Research, Malaysia: Ministry of Science, Technology and Innovation of Malaysia (grant number: 100--IRDC/BIOTEK 16/6/21 (13/2007), and 07-05--IFN--BPH 010), Ministry of Higher Education of Malaysia (grant number: 600-RMI/LRGS/5/3 (2/2011)), Universiti Teknologi MARA, Universiti Kebangsaan Malaysia (UKM-Hejim-Komuniti-15-2010), occupied Palestinian territory: the United Nations Relief and Works Agency for Palestine Refugees in the Near East, occupied Palestinian territory, International Development Research Centre, Canada, Philippines: Philippine Council for Health Research and Development, Poland: Polish Ministry of Science and Higher Education (grant number: 290/W--PURE/2008/0), Wroclaw Medical University, Saudi Arabia: Saudi Heart Association, Saudi Gastroenterology Association, Dr. Mohammad Alfagih Hospital, The Deanship of Scientific Research at King Saud University, Riyadh, Saudi Arabia (Research group number: RG -1436-013), South Africa: The North--West University, SA and Netherlands Programme for Alternative Development, National Research Foundation, Medical Research Council of South Africa, The South Africa Sugar Association, Faculty of Community and Health Sciences, Sweden: grants from the Swedish state under the Agreement concerning research and education of doctors, the Swedish Heart and Lung Foundation, the Swedish Research Council, the Swedish Council for Health, Working Life and Welfare, King Gustaf V:s and Queen Victoria Freemason's Foundation, AFA Insurance, Turkey: Metabolic Syndrome Society, AstraZeneca, Sanofi Aventis, United Arab Emirates: Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences and Dubai Health Authority, Dubai.

El estudio fue financiado principalmente por el Population Health Research Institute (PHRI). SY cuenta con el apoyo de la cátedra Mary W Burke de la Heart and Stroke Foundation de Ontario. El estudio PURE es un estudio iniciado por investigadores que está financiado por el Population Health Research Institute, Hamilton Health Sciences Research Institute (HHSRI), los Canadian Institutes of Health Research, Heart and Stroke Foundation de Ontario, apoyo de la Estrategia para la Investigación Orientada al Paciente de los Canadian Institutes of Health Research, a través de la Unidad de Apoyo SPOR de Ontario, así como el Ministerio de Salud y Cuidados a Largo Plazo de Ontario y a través de subvenciones sin restricciones de varias compañías farmacéuticas (con importantes contribuciones de AstraZeneca (Canadá), Sanofi-Aventis (Francia y Canadá), Boehringer Ingelheim (Alemania y Canadá), Servier y GlaxoSmithKline), y contribuciones adicionales de Novartis y King Pharma y de varias organizaciones nacionales o locales en los países participantes. Estos incluyen: Argentina: Fundación ECLA (Estudios Clínicos Latinoamericanos); Bangladesh: Independent University, Bangladesh y Mitra and Associates; Brasil: Unilever Health Institute, Brasil; Canadá: este estudio fue financiado mediante una subvención sin restricciones de Dairy Farmers of Canada y el National Dairy Council (EE. UU.), la Agencia de Salud Pública de Canadá y Champlain Cardiovascular Disease Prevention Network; Chile: Universidad de la Frontera; China: Centro Nacional de Enfermedades Cardiovasculares y ThinkTank Research Center for Health Development; Colombia: Colciencias (subvención 6566-04-18062 y subvención 6517-777-58228); India: Consejo Indio de Investigación Médica; Malasia: Ministerio de Ciencia, Tecnología e Innovación de Malasia (número de subvención: 100--IRDC/BIOTEK 16/6/21 (13/2007), y 07-05--IFN--BPH 010), Ministerio de Educación Superior de Malasia (número de subvención: 600-RMI/LRGS/5/3 (2/2011)), Universiti Teknologi MARA, Universiti Kebangsaan Malaysia (UKM-Hejim-Komuniti-15-2010); territorio palestino ocupado: Organismo de Obras Públicas y Socorro de las Naciones Unidas para los Refugiados de Palestina en el Cercano Oriente, territorio palestino ocupado; Centro Internacional de Investigaciones para el Desarrollo, Canadá; Filipinas: Consejo Filipino para la Investigación y el Desarrollo en Salud; Polonia: Ministerio de Ciencia y Educación Superior de Polonia (número de subvención: 290/W--PURE/2008/0), Universidad Médica de Wroclaw; Arabia Saudita: Asociación Saudita del Corazón, Asociación Saudita de Gastroenterología, Hospital Dr. Mohammad Alfagih, Decanato de Investigación Científica en la Universidad Rey Saud, Riad, Arabia Saudita (número de grupo de investigación: RG-1436-013); Sudáfrica: Universidad del Noroeste, Sudáfrica y Programa de los Países Bajos para el Desarrollo Alternativo, Fundación Nacional de Investigación, Consejo de Investigación Médica de Sudáfrica, Asociación Sudafricana del Azúcar, Facultad de Ciencias de la Comunidad y la Salud; Suecia: subvenciones del estado sueco bajo el Acuerdo sobre investigación y educación de médicos; Fundación Sueca del Corazón y los Pulmones; Consejo Sueco de Investigación; Consejo Sueco para la Salud, la Vida Laboral y el Bienestar, Fundación de los Francmasones Rey Gustavo V y Reina Victoria, AFA Insurance; Turquía: Sociedad del Síndrome Metabólico, AstraZeneca, Sanofi Aventis; Emiratos Árabes Unidos: Premio Sheikh Hamdan Bin Rashid Al Maktoum para Ciencias Médicas y Autoridad de Salud de Dubái, Dubái.

The study was mainly funded by the Population Health Research Institute (PHRI). SY is supported by the Mary W Burke endowed chair of the Heart and Stroke Foundation of Ontario. The PURE study is an investigator--initiated study that is funded by the Population Health Research Institute, Hamilton Health Sciences Research Institute (HHSRI), the Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario, Support from Canadian Institutes of Health Research's Strategy for Patient Oriented Research, through the Ontario SPOR Support Unit, as well as the Ontario Ministry of Health and Long--Term Care and through unrestricted grants from several pharmaceutical companies (with major contributions from AstraZeneca (Canada), Sanofi--Aventis (France and Canada), Boehringer Ingelheim (Germany and Canada), Servier, and GlaxoSmithKline), and additional contributions from Novartis and King Pharma and from various national or local organizations in participating countries.These include: Argentina: Fundacion ECLA (Estudios Clinicos Latino America); Bangladesh: Independent University, Bangladesh and Mitra and Associates; Brazil: Unilever Health Institute, Brazil; Canada: this study was supported by an unrestricted grant from Dairy Farmers of Canada and the National Dairy Council (US), Public Health Agency of Canada and Champlain Cardiovascular Disease Prevention Network; Chile: Universidad de la Frontera; China: National Center for Cardiovascular Diseases and ThinkTank Research Center for Health Development; Colombia: Colciencias (grant 6566-04-18062 and grant 6517-777-58228); India: Indian Council of Medical Research; Malaysia: Ministry of Science, Technology and Innovation of Malaysia (grant number: 100--IRDC/BIOTEK 16/6/21 (13/2007), and 07-05--IFN--BPH 010), Ministry of Higher Education of Malaysia (grant number: 600-RMI/LRGS/5/3 (2/2011)), Universiti Teknologi MARA, Universiti Kebangsaan Malaysia (UKM-Hejim-Komuniti-15-2010); occupied Palestinian territory: the United Nations Relief and Works Agency for Palestine Refugees in the Near East, occupied Palestinian territory; International Development Research Centre, Canada; Philippines: Philippine Council for Health Research and Development; Poland: Polish Ministry of Science and Higher Education (grant number: 290/W--PURE/2008/0), Wroclaw Medical University; Saudi Arabia: Saudi Heart Association, Saudi Gastroenterology Association, Dr. Mohammad Alfagih Hospital, The Deanship of Scientific Research at King Saud University, Riyadh, Saudi Arabia (Research group number: RG -1436-013); South Africa: The North--West University, SA and Netherlands Programme for Alternative Development, National Research Foundation, Medical Research Council of South Africa, The South Africa Sugar Association, Faculty of Community and Health Sciences; Sweden: grants from the Swedish state under the Agreement concerning research and education of doctors; the Swedish Heart and Lung Foundation; the Swedish Research Council; the Swedish Council for Health, Working Life and Welfare, King Gustaf V:s and Queen Victoria Freemason's Foundation, AFA Insurance; Turkey: Metabolic Syndrome Society, AstraZeneca, Sanofi Aventis; United Arab Emirates: Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences and Dubai Health Authority, Dubai.

10.1136/bmjdrc-2019-000826

pdf

nutrition

hypertension

endocrinology

adult diabetes

Endocrinología y Metabolismo

nutrición

hipertensión

endocrinología

diabetes en adultos

Endocrinología y Metabolismo (Incluye Diabetes, Hormonas)

WOS:000548921800001

acceso abierto

acceso abierto

pdf

Association of dairy consumption with metabolic syndrome, hypertension and diabetes in 147 812 individuals from 21 countries

artículo original

version publicada

BMJ PUBLISHING GROUP

BMJ OPEN DIABETES RESEARCH & CARE

Endocrinología y Metabolismo

en

The study was mainly funded by the Population Health Research Institute (PHRI). SY is supported by the Mary W Burke endowed chair of the Heart and Stroke Foundation of Ontario. The PURE study is an investigator--initiated study that is funded by the Population Health Research Institute, Hamilton Health Sciences Research Institute (HHSRI), the Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario, Support from Canadian Institutes of Health Research's Strategy for Patient Oriented Research, through the Ontario SPOR Support Unit, as well as the Ontario Ministry of Health and Long--Term Care and through unrestricted grants from several pharmaceutical companies (with major contributions from AstraZeneca (Canada), Sanofi--Aventis (France and Canada), Boehringer Ingelheim (Germany and Canada), Servier, and GlaxoSmithKline), and additional contributions from Novartis and King Pharma and from various national or local organizations in participating countries.These include: Argentina: Fundacion ECLA (Estudios Clinicos Latino America), Bangladesh: Independent University, Bangladesh and Mitra and Associates, Brazil: Unilever Health Institute, Brazil, Canada: this study was supported by an unrestricted grant from Dairy Farmers of Canada and the National Dairy Council (US), Public Health Agency of Canada and Champlain Cardiovascular Disease Prevention Network, Chile: Universidad de la Frontera, China: National Center for Cardiovascular Diseases and ThinkTank Research Center for Health Development, Colombia: Colciencias (grant 6566-04-18062 and grant 6517-777-58228), India: Indian Council of Medical Research, Malaysia: Ministry of Science, Technology and Innovation of Malaysia (grant number: 100--IRDC/BIOTEK 16/6/21 (13/2007), and 07-05--IFN--BPH 010), Ministry of Higher Education of Malaysia (grant number: 600-RMI/LRGS/5/3 (2/2011)), Universiti Teknologi MARA, Universiti Kebangsaan Malaysia (UKM-Hejim-Komuniti-15-2010), occupied Palestinian territory: the United Nations Relief and Works Agency for Palestine Refugees in the Near East, occupied Palestinian territory, International Development Research Centre, Canada, Philippines: Philippine Council for Health Research and Development, Poland: Polish Ministry of Science and Higher Education (grant number: 290/W--PURE/2008/0), Wroclaw Medical University, Saudi Arabia: Saudi Heart Association, Saudi Gastroenterology Association, Dr. Mohammad Alfagih Hospital, The Deanship of Scientific Research at King Saud University, Riyadh, Saudi Arabia (Research group number: RG -1436-013), South Africa: The North--West University, SA and Netherlands Programme for Alternative Development, National Research Foundation, Medical Research Council of South Africa, The South Africa Sugar Association, Faculty of Community and Health Sciences, Sweden: grants from the Swedish state under the Agreement concerning research and education of doctors, the Swedish Heart and Lung Foundation, the Swedish Research Council, the Swedish Council for Health, Working Life and Welfare, King Gustaf V:s and Queen Victoria Freemason's Foundation, AFA Insurance, Turkey: Metabolic Syndrome Society, AstraZeneca, Sanofi Aventis, United Arab Emirates: Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences and Dubai Health Authority, Dubai.

PHRI

Heart and Stroke Foundation of Ontario

HHSRI

CIHR

Ontario Ministry of Health and Long-Term Care

AstraZeneca (Canada)

Sanofi-Aventis (France)

Sanofi-Aventis (Canada)

Boehringer Ingelheim (Germany)

Boehringer Ingelheim (Canada)

Servier

GlaxoSmithKline

Dairy Farmers of Canada

National Dairy Council (US)

Public Health Agency of Canada

Champlain Cardiovascular Disease Prevention Network

UFRO

National Center for Cardiovascular Diseases

ThinkTank Research Center for Health Development

ColCiencias 6566-04-18062

ColCiencias 6517-777-58228

Indian Council of Medical Research

MOSTI 100-IRDC/BIOTEK 16/6/21 (13/2007), 07-05-IFN-BPH 010

MOHE 600-RMI/LRGS/5/3 (2/2011)

Universiti Teknologi MARA

Universiti Kebangsaan Malaysia UKM-Hejim-Komuniti-15-2010

Polish Ministry of Science and Higher Education, Wroclaw Medical University 290/W--PURE/2008/0

Deanship of Scientific Research at King Saud University, Riyadh RG -1436-013

Swedish Heart and Lung Foundation

Swedish Research Council

Swedish Council for Health, Working Life and Welfare

King Gustaf V:s and Queen Victoria Freemason's Foundation

AFA Insurance

Heart and Stroke

HHHSRI

CHRI

AstraZeneca Canada

Sanofi-Aventis France

Sanofi-Aventis Canada

Boehringer Ingelheim Germany

Boehringer Ingelheim Canada

National Dairy Council US

Chile: UFRO

China: National Center for Cardiovascular Diseases

China: ThinkTank Research Center for Health Development

MOSTI 100-IRDC/BIOTEK 16/6/21 13/2007

MOSTI 07-05-IFN-BPH 010

MOHE 600-RMI/LRGS/5/3 2/2011

NAUCA Wroclaw Medical University 290/W--PURE/2008/0

Deanship of Scientific Research at King Saud University, Riyadh, Saudi Arabia RG -1436-013

dorada

verde